Skillman, NJ, United States of America

David A Mathre

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David A. Mathre: Innovator in Peptide Chemistry

Introduction

David A. Mathre is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of peptide chemistry, particularly through his innovative processes for forming amide bond linkages. His work has implications for the development of biologically active compounds.

Latest Patents

David A. Mathre holds a patent for a process titled "Process for Peptide Segment Condensation." This invention involves a method for forming an amide bond by reacting a carboxylic acid and an amine in a two-phase mixture of water and an organic solvent. The process utilizes a coupling reagent and an additive, making it useful for synthesizing amides and polypeptides with various biological activities. He has 1 patent to his name.

Career Highlights

David A. Mathre is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to further his research and development efforts in the pharmaceutical industry. His expertise in peptide chemistry has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, David has collaborated with several talented individuals, including Khateeta M. Emerson and Guo-Jie Ho. These collaborations have contributed to the advancement of research in peptide synthesis and related areas.

Conclusion

David A. Mathre's contributions to peptide chemistry and his innovative processes have made a significant impact in the field. His work continues to influence the development of biologically active compounds, showcasing the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…